A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles
- PMID: 28188071
- DOI: 10.1016/j.jcyt.2017.01.001
A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles
Abstract
Background aims: Extracellular vesicles (EVs) released by mesenchymal stromal cells (MSCs) may contribute to biological processes such as tissue regeneration, immunomodulation and neuroprotection. Evaluation of their therapeutic potential and application in future clinical trials demands thorough characterization of EV content and production under defined medium conditions, devoid of xenogenic substances and serum-derived vesicles. Addressing the apparent need for such a growth medium, we have developed a medium formulation based on pooled human platelet lysate (pHPL), free from animal-derived xenogenic additives and depleted of EVs.
Methods: Depletion of EVs from complete growth medium was achieved by centrifugation at 120 000 g for 3 h, which reduced RNA-containing pHPL EVs to below the detection limit.
Results: Bone marrow (BM)-derived MSCs propagated in this medium retained the characteristic surface marker expression, cell morphology, viability and in vitro osteogenic and adipogenic differentiation potential. The proliferation rate was not significantly affected after 48 h but was decreased by 13% after 96 h. EVs collected from BM-MSCs cultured in EV-depleted medium revealed a similar RNA pattern as EVs generated in standard pHPL EV-containing medium but displayed a more clearly defined pattern of proteins characteristic for EVs. Reduction of pHPL content from 10% to 2% or serum-/pHPL-free conditions strongly altered MSC characteristics and RNA content of released EV.
Conclusions: The 10% pHPL-based EV-depleted medium is appropriate for purification of exclusively human MSC-derived EVs. With this Good Manufacturing Practice-grade protocol, characterization and establishment of protein and RNA profiles from MSC-derived EVs can now be achieved to identify active components in therapeutic EVs for future clinical application.
Keywords: EV depletion; Good Manufacturing Practice; exosomes; extracellular vesicles; human platelet lysate; mesenchymal stromal cells.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.Stem Cells Transl Med. 2015 Oct;4(10):1131-43. doi: 10.5966/sctm.2015-0078. Epub 2015 Sep 3. Stem Cells Transl Med. 2015. PMID: 26339036 Free PMC article.
-
Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles.J Mol Med (Berl). 2017 Feb;95(2):205-220. doi: 10.1007/s00109-016-1471-7. Epub 2016 Sep 16. J Mol Med (Berl). 2017. PMID: 27638341 Free PMC article.
-
Calcium chloride declotted human platelet lysate promotes the expansion of mesenchymal stromal cells and allows manufacturing of immunomodulatory active extracellular vesicle products.Cytotherapy. 2024 Sep;26(9):988-998. doi: 10.1016/j.jcyt.2024.04.069. Epub 2024 Apr 27. Cytotherapy. 2024. PMID: 38819364
-
Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.Cytotherapy. 2019 Jun;21(6):581-592. doi: 10.1016/j.jcyt.2018.12.006. Epub 2019 Apr 9. Cytotherapy. 2019. PMID: 30979664 Review.
-
Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents.Int J Mol Sci. 2017 Jul 6;18(7):1450. doi: 10.3390/ijms18071450. Int J Mol Sci. 2017. PMID: 28684664 Free PMC article. Review.
Cited by
-
The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.Am J Reprod Immunol. 2021 Feb;85(2):e13329. doi: 10.1111/aji.13329. Epub 2020 Sep 12. Am J Reprod Immunol. 2021. PMID: 32846024 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Therapeutic Use and in Bioengineering Applications.Cells. 2022 Oct 25;11(21):3366. doi: 10.3390/cells11213366. Cells. 2022. PMID: 36359762 Free PMC article. Review.
-
Label-free characterization of an extracellular vesicle-based therapeutic.J Extracell Vesicles. 2021 Oct;10(12):e12156. doi: 10.1002/jev2.12156. J Extracell Vesicles. 2021. PMID: 34669269 Free PMC article.
-
Cell culture-derived extracellular vesicles: Considerations for reporting cell culturing parameters.J Extracell Biol. 2023 Oct 16;2(10):e115. doi: 10.1002/jex2.115. eCollection 2023 Oct. J Extracell Biol. 2023. PMID: 38939735 Free PMC article.
-
Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.Int J Nanomedicine. 2019 Nov 12;14:8847-8859. doi: 10.2147/IJN.S225453. eCollection 2019. Int J Nanomedicine. 2019. PMID: 32009783 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources